AlphaCore Reports Positive Phase 1 Results For New Heart DrugAlphaCore Pharma announced Tuesday that results from the company’s Phase 1 clinical trial have met the primary endpoint by demonstrating the safety and tolerability of the drug ACP-501 (recombinant human LCAT).
AlphaCore Pharma Starts Clinical Trial Of New Heart DrugThe biopharmaceutical company AlphaCore Pharma Friday announced it had started a Phase 1 study of its drug candidate, ACP-501, for the treatment of high-risk atherosclerosis and serious lipid metabolism disorders.
Ann Arbor Firm Part Of Cholesterol Treatment GrantAnn Arbor-based AlphaCore Pharma and Rockville, Md.-based Advanced Bioscience Laboratories Tuesday announced funding from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to manufacture a new treatment for a type of coronary artery disease that runs in families.

More From CBS Detroit

Best Fall Festivals In Metro DetroitFrom music to art to special events, there's a little something for everyone's delight.
Best 4th Of July Concerts In Metro DetroitStaying home this weekend? Celebrate the 4th of July by rocking out at one of these shows.
Hump Day Drinks: 8 Cheery Cocktail RecipesNow that you've made it through half the work week, it's time to celebrate!

Watch & Listen